Redox Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 176.47%
(FY 2016)
- Profit -66.48%
(FY 2016)
- Ebitda -66.48%
(FY 2016)
- Net Worth -1.99%
(FY 2016)
- Total Assets -73.58%
(FY 2016)
About Redox Laboratories (India)
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Podagatlapalli Prasad and Podagatlapalli Swathi serve as directors at the Company.
- CIN/LLPIN
U24100AP2013PTC092038
- Company No.
092038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Redox Laboratories (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Podagatlapalli Prasad  | Managing Director | 31-Dec-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Podagatlapalli Swathi | Director | 31-Dec-2013 | Current |
Financial Performance of Redox Laboratories (India).
Redox Laboratories (India) Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 176.47% increase. The company also saw a substantial fall in profitability, with a 66.48% decrease in profit. The company's net worth dipped by a decrease of 1.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Redox Laboratories (India)?
In 2017, Redox Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suvi Biofuels Private LimitedActive 6 years 9 monthsPodagatlapalli Prasad and Podagatlapalli Swathi are mutual person
- Ekalp Learning Solutions Private LimitedActive 3 years 8 months
Podagatlapalli Prasad and Podagatlapalli Swathi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Redox Laboratories (India)?
Unlock and access historical data on people associated with Redox Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Redox Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redox Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
